Jae Jung is an exceptional scholar, leader and teacher whose contributions to the health of society are immeasurable.
Jae Jung, PhD Distinguished Professor and Chair of Molecular Microbiology and Immunology Department Hastings Foundation Professor and Fletcher Jones Foundation Chair Director of USC Institute of Emerging Pathogens and Immune Diseases
Dr. Jae U. Jung is a preeminent expert in the molecular biology of viruses and their gene products as they relate to cell biology, biochemistry and immunology. His research addresses several key biological features of virus-host interactions, with a focus on host immune responses to viruses, mechanisms by which viruses induce tumors, and the ability of viruses to evade host immunity and establish life-long infections.
He has published over 210 publications on highly peer-reviewed journals and serves as Principal Investigator to several NIH and foundation grants. He is a Fellow of the American Academy of Microbiology and the American Association for the Advancement of Science. In 2012, he received the Ho-Am Prize in Medicine, one of Korea’s highest honors and often referred to as the Korean equivalent of the Nobel Prize. Prior to his appointment at USC in 2007, he was a Professor of Microbiology and Molecular Genetics at Harvard Medical School and Chair of Tumor Virology Division at the New England Primate Research Center. He was the first Korean-born scientist to receive tenure at Harvard University. He received his PhD from the University of California, Davis in 1989 and his BS and MS from Seoul National University in Korea in 1982 and 1984 respectively.
At USC, Dr. Jung has and will continue to strengthen the basic science and translational research and the faculty’s significant contributions in the arena of scientific discovery. He has recruited top-notch investigators, organized multi-investigator program grant award for centers of excellence, and enhanced active core facilities to stimulate the research environment. He continues to integrate programs to bridge gaps between basic science and clinical research, and promote multidisciplinary translation research on the most pressing diseases including AIDS, tuberculosis, flu, emerging diseases, autoimmune diseases, and cancers.
About Jae Jung, PhD
Jae Jung’s laboratory is conducting research in host-pathogen standoff, virus-induced malignancy and epigenetic regulation, programmed cell death, emerging pathogens and immune aging for infection.